VNDA Earnings

Quarterly EPS
$-0.09
Q3 2024
$-0.08
Q4 2024
$-0.50
Q1 2025
$-0.46
Q2 2025
$-0.38
Q3 2025
$-2.39
Q4 2025
$-0.82
Q1 2026
$-1.04
Q2 2026
Latest Revenue50.5M
Latest Net Income-62513000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$1.0450.5M-62513000-3.9%-126.1%
Q1 2026-$0.8251.7M-48567000+3.4%-64.0%
Q4 2025-$2.3957.2M-141187000+7.6%-2,887.5%
Q3 2025-$0.3856.3M-22586000+18.1%-322.2%
Q2 2025-$0.4652.6M-27207000+4.2%-475.0%
Q1 2025-$0.5050.0M-29494000+5.4%-614.3%
Q4 2024-$0.0853.2M-4912000+17.5%-100.0%
Q3 2024-$0.0947.7M-5324000+22.8%
Q2 2024-$0.0850.5M-4518000
Q1 2024-$0.0747.5M-4146000
Q4 2023-$0.0445.3M-2400000
Q3 2023$0.0038.8M137.0K
Vanda Pharmaceuticals (VNDA) — Earnings